Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
GRDX · 10-Q filed August 21, 2026

GRDX earnings analysis

What we found in GRDX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The filing provides no current-period income statement, balance-sheet, cash-flow, or segment figures in the extracted text, so revenue, margins, EPS, liquidity, and free cash flow cannot be assessed. The principal disclosed developments are an approximately $10.1 million goodwill impairment tied to commercialization and contract-execution delays, a material weakness in internal controls, and a $2,057,600 arbitration claim with a $202,000 accrual. The Ellenoff Grossman & Schole matter was settled for $360,000 and discontinued with prejudice, but the overall filing signals elevated execution, reporting, and litigation risk.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Legal-fee litigation settled
The Company settled the Ellenoff Grossman & Schole legal-fee dispute for $360,000, including an initial $100,000 payment and three equal installment payments over one year. The litigation was discontinued with prejudice on May 14, 2026.
Commercialization issue quantified
Management identified a specific commercialization and customer-execution issue: delays during the three months ended June 30, 2026 resulted in lower-than-projected operating results and contributed to a goodwill impairment charge of approximately $10.1 million.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Material weakness in controls
The Company reported that its disclosure controls and procedures were not effective as of June 30, 2026 because of a material weakness related to the integration of Grid AI Corp., including insufficient accounting resources and processes for timely and accurate financial reporting.
Execution delays and impairment risk
The Company disclosed that delays in commercialization and customer contract execution contributed to an approximately $10.1 million goodwill impairment charge. It warned that further delays or failure to achieve projections could materially adversely affect results.
WestPark arbitration exposure
WestPark Capital is seeking approximately $2,057,600 in an arbitration proceeding, and the Company has recorded a $202,000 accrual. Management stated that the outcome cannot currently be reasonably predicted.
Guidance

What they said about what is next.

No quantitative revenue or EPS guidance was provided in the extracted 10-Q; the filing states that delays in commercialization and customer contract execution resulted in lower-than-projected operating results.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 27, 2026
GridAI Technologies Corp. reported significant changes in its financial results following the acquisition of Grid AI Corp. The company generated revenue of $38,208 in Q1 2026 from its AI Segment, marking a shift from…
10-K · May 1, 2026
GridAI Technologies Corp. reported a net loss of approximately $6.55 million for 2025, a substantial decrease from an $18.06 million loss in 2024, driven by the acquisition of Grid AI Corp. and the subsequent…
10-Q · November 19, 2025
Entero reported substantially narrower operating losses and a smaller GAAP net loss in Q3 2025 versus prior-year periods, driven in part by reduced operating expenses and one-time transaction activity. The balance sheet…
10-K · April 1, 2025
Entero (formerly First Wave Biopharma) has refocused on Adrulipase for exocrine pancreatic insufficiency after discontinuing multiple prior programs and completing (and now arranging to rescind) a March 2024 merger with…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing GRDX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever